Brooklyn Investment Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.03M Buy
49,904
+18,954
+61% +$1.1M 0.09% 174
2025
Q4
$1.67M Buy
30,950
+17,005
+122% +$818K 0.08% 206
2025
Q3
$646K Buy
13,945
+133
+1% +$6.21K 0.09% 223
2025
Q2
$639K Buy
13,812
+380
+3% +$18.7K 0.08% 233
2025
Q1
$819K Sell
13,432
-2,636
-16% -$154K 0.18% 111
2024
Q4
$909K Buy
16,068
+7,866
+96% +$440K 0.27% 70
2024
Q3
$424K Sell
8,202
-6,179
-43% -$290K 0.14% 131
2024
Q2
$762K Hold
14,381
0.33% 71
2024
Q1
$762K Buy
14,381
+6,021
+72% +$307K 0.33% 71
2023
Q4
$429K Buy
+8,360
New +$439K 0.2% 113

Other funds holding BMY

Brooklyn Investment Group's BMY Position: Q1 2026 in Review

Brooklyn Investment Group increased its Bristol-Myers Squibb (BMY) stake by 61% in Q1 2026, buying an estimated $1.1M and bringing the position to 49,904 shares worth $3.03M. The position accounts for 0.09% of the portfolio, ranked #174.

Brooklyn Investment Group first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Brooklyn Investment Group held 49,904 shares of Bristol-Myers Squibb worth $3.03M as of Q1 2026.
  • Brooklyn Investment Group bought 18,954 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.1M.
  • Bristol-Myers Squibb made up 0.09% of Brooklyn Investment Group's portfolio in Q1 2026, its #174 holding.
  • Brooklyn Investment Group first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.